Catella advises Bonum Development, SEBC on sale of Copenhagen-area Falkely apartments to CBRE IM

Catabasis Pharmaceuticals Inc
CBRE Group, Inc. Class A

Catabasis Pharmaceuticals Inc

CATB

0.00

CBRE Group, Inc. Class A

CBRE

0.00
  • Catella advised Bonum Development, SEBC on the sale of Falkely, a newly built Greater Copenhagen residential asset, to CBRE Investment Management.
  • Property totals 9,788 sq m, comprises 132 apartments in Ishøj; project completed at end-January 2026.
  • Transaction reflects renewed institutional demand for stabilized Copenhagen-area residential, supported by constrained supply, population growth, resilient rents.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catella AB published the original content used to generate this news brief on June 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.